Chairman, Department of Pathology and Laboratory Medicine
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Dr. Elenitoba-Johnson is the inaugural Chair of the Department of Pathology and Laboratory Medicine, and Member of the Human Oncology & Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center. Prior to this appointment, he was the Director of the Center of Personalized Diagnostics, and the inaugural Peter C. Nowell, M.D., Endowed Professor, in the Department of Pathology and Laboratory Medicine at Penn Medicine, Perelman School of Medicine, at the University of Pennsylvania from 2015 to August 2022.
He is a recognized pioneer in lymphoma proteomics, and a top leader in precision and integrated diagnostics. His work is notable for the identification and mechanistic elucidation of targetable genetic alterations underlying the pathogenesis of specific lymphoma subtypes.
Dr. Elenitoba-Johnson is an elected member of the National Academy of Medicine, the American Society for Clinical Investigation and the International Lymphoma Study Group. (2017) and has been recognized with numerous profession honors and awards, notably the Ramzi Cotran Young Investigator Award from the United States and Canadian Academy of Pathology, the Outstanding Investigator (Former Warner-Lambert-Parke Davis) Award from the American Society for Investigative Pathology and the William Gerald Award from Memorial Sloan Kettering Cancer Center.
Insights with Impact: Empowering Laboratories with a Decentralized MSK Solution for CGP
Wednesday, November 20, 2024
11:00 AM – 11:50 AM PST